本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Encompass Health Corporation

124.60
-0.6900-0.55%
盤後124.00-0.6000-0.48%19:55 EDT
成交量:50.79萬
成交額:6,316.91萬
市值:125.50億
市盈率:24.39
高:126.00
開:125.24
低:123.40
收:125.29
52周最高:126.49
52周最低:87.85
股本:1.01億
流通股本:9,922.21萬
量比:0.81
換手率:0.51%
股息:0.68
股息率:0.55%
每股收益(TTM):5.11
每股收益(LYR):4.53
淨資產收益率:24.72%
總資產收益率:9.18%
市淨率:5.50
市盈率(LYR):27.48

資料載入中...

2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/07/29

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/29

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/29

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/26

重要事件披露

Form 8-K - Current report
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/02

重要事件披露

Form 8-K - Current report
2025/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/25

重要事件披露

Form 8-K - Current report
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/21

重要事件披露

Form 8-K - Current report
2025/02/06

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]